Joseph Truitt

Chairman at LARIMAR THERAPEUTICS, INC.

Net worth: 9 570 $ as of 30/05/2026

61 year

Health Technology

Consumer Services

Profile

Joseph Truitt is Chief Executive Officer & Director at iECURE, Inc. since 2021.
Mr. Truitt is Chairman at Larimar Therapeutics, Inc. since 2020.
Mr. Truitt is Director at Code Biotherapeutics, Inc. since 2020.
Former roles include Chief Executive Officer & Director at BioSpecifics Technologies Corp.
in 2020.
President, Chief Executive Officer & Director at Achillion Pharmaceuticals, Inc. from 2018 to 2020.
Vice President-Sales & Operations at Johnson & Johnson in 2006.
Vice President-Sales & Operations at OraPharma, Inc. in 2002.
VP-Business Development & Product Strategy at Lev Pharmaceuticals, Inc. from 2007 to 2008.
Education includes undergraduate studies at LaSalle University and an MBA from St. Joseph's University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
LARIMAR THERAPEUTICS, INC. 0%	18/05/2026	2,750 ( 0% )	9 570 $	30/05/2026

Joseph Truitt active positions

Companies	Position	Start
LARIMAR THERAPEUTICS, INC.	Chairman	27/05/2020
Code Biotherapeutics, Inc. Code Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company	Director/Board Member	30/11/2020
IEcure, Inc. IEcure, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage biotechnology company that develops in-vivo gene insertion/editing therapies to treat rare liver disorders	Chief Executive Officer	28/02/2021

All active positions of Joseph Truitt

Former positions of Joseph Truitt

Companies	Position	End
BIOSPECIFICS TECHNOLOGIES CORP.	Chief Executive Officer	01/12/2020
ACHILLION PHARMACEUTICALS, INC.	Chief Executive Officer	27/01/2020
Lev Pharmaceuticals, Inc. Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products for the treatment of inflammatory diseases	Corporate Officer/Principal	30/11/2008
JOHNSON & JOHNSON	Chief Operating Officer	30/06/2006
OraPharma, Inc. OraPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces drugs for oral diseases	Chief Operating Officer	31/12/2001

See the detail of Joseph Truitt's experience

Training of Joseph Truitt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joseph Truitt's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Johnson & Johnson Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products	Health Technology
BioSpecifics Technologies Corp. BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology Develops injectable collagenase clostridium histolyticum (CCH) for multiple indications	Health Technology
OraPharma, Inc. OraPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces drugs for oral diseases	Health Technology
Achillion Pharmaceuticals, Inc. Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases	Health Technology
LaSalle University LaSalle University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
St. Joseph's University St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lev Pharmaceuticals, Inc. Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products for the treatment of inflammatory diseases	Health Technology
Larimar Therapeutics, Inc. Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases	Health Technology
Code Biotherapeutics, Inc. Code Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company	Health Technology
IEcure, Inc. IEcure, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage biotechnology company that develops in-vivo gene insertion/editing therapies to treat rare liver disorders	Health Technology